SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending after a sharp breakout through long-standing resistance, pushing the price to its highest level since January and triggering heavy short liquidations. Bulls declare the crypto winter overciting the first weekly close above the 50-week moving average in monthswhile skeptics warn the move is manipulation or a bull trap that could reverse.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoin's rally to its highest levels since January is lifting Strategy shares sharply higher, with traders crediting the crypto breakout, short-squeeze momentum, and the company's continued bitcoin purchases. Bulls are celebrating the move while skeptics warn the stock trades at a premium to its bitcoin holdings and could face dilution from future capital raises.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is surging on President Trump's announced U.S.DenmarkGreenland security pact granting the U.S. permanent military access to Greenland and authority to block adversarial investments, lifting the rare-earth developer alongside fellow Greenland-linked names in extended trading. Retail reaction is overwhelmingly bullish with heavy short-squeeze speculation and many traders tying the timing to the upcoming TrumpXi meeting on critical minerals, though skeptics note the pact secures jurisdiction rather than directly funding or advancing the Tanbreez rare-earth project.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is rallying sharply and testing a key resistance level that has capped rallies for months, with traders attributing the move to short liquidations, whale accumulation, and a broader crypto rebound. Sentiment is split between bulls pointing to the SEC and CFTC advancing crypto market rules after the Clarity Act stalled in the Senate, and skeptics who see the move as a short squeeze with the token still tracking Bitcoin.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk shares slid after its Capital Markets Day, where long-term targets including plans for multiple new blockbuster launches by 2030 and revenue growth guided only at peer pace failed to ease concerns over semaglutide patent expirations and competition from Eli Lilly. Traders are divided between calling the selloff an overreaction on an oversold stock and criticizing management's execution and vision, while some speculate the drop reflects deliberate selling pressure rather than fundamentals.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is trending on its confirmed 20-year, 207 MW power purchase agreement with Vistra for its Texas data center campus, which traders are celebrating as a major de-risking milestone that shifts power economics fully to NUAI rather than through partner Stream. The community is overwhelmingly bullish, with many speculating a hyperscaler tenant lease is the next catalyst, though some posters note the site still lacks a signed tenant.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

COIN is rallying as the CLARITY Act's Senate failure gives way to a regulatory pivot traders view as favorable  the SEC's five-year tokenized-stock exemption and Coinbase's CFTC filing for single-stock perpetual futures, reinforced by CEO Brian Armstrong's argument that the bill's defeat limits bank competition  alongside Bitcoin's rebound to multi-month highs. Bulls frame tokenization and heavy short interest as a squeeze setup, while bears dismiss the move as an options-expiration pump that will fade.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Traders are zeroing in on reports that AMD has notified customers of a roughly 10% chip price increase beginning in the fourth quarter, linked to higher TSMC wafer costs, as the stock rallies toward all-time highs amid short-squeeze activity. The community is divided on the hike, with some reading it as a sign of pricing power and others warning it could pressure demand or merely pass through TSMC's cost increases without boosting margins.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is surging as the SEC's innovation exemption allowing on-chain trading of tokenized U.S. securities fuels a tokenization narrative that traders view as a major tailwind for the network, with the move marked by a breakout above prior range highs and short liquidations. Community reaction is split between bulls touting continued upside and buy-the-dip staking, and skeptics warning of pullback risk in the post-Fed rate-hike environment and noting Solana is lagging the outperformance of rivals like Zcash and NEAR.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel is trending amid a sharp selloff and a heated community split over CEO Paul Peter Tak's pre-planned 10b5-1 sale of roughly 280,000 shares, which  coming alongside his characterization of the BLA timeline as "extremely tight" and a pushed-back completion date for the PrTK05 biomarker study  has fueled speculation the planned Q4 BLA submission could slip. Bulls call the sale routine and point to upcoming catalysts such as the ASTRO presentations and a quarterly biomarker readout, while bears argue the timing signals weak management confidence and coming dilution.

statis crypto Watchlist

Ethereum

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BTSG Faces $200M IRA Hit but Efficiency May Protect Profitability

BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.

Can CAH Navigate IRA Pricing Changes Risk Without Margin Pressure?

Cardinal Health expects IRA pricing changes to pressure Pharma revenues while protecting profitability through compensation and durable distribution agreements.

Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading day saw Cardinal Health (CAH) settling at $232.36, representing a -1.08% change from its previous close.

CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?

Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.

Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cardinal Health (CAH) Declines More Than Market: Some Information for Investors

In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?

Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

Here's Why Cardinal Health (CAH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen

Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.

Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy?

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Specialty Solutions Segment and Global Medical Products and Distribution Segment. The Pharmaceutical and Specialty Solutions Segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution Segment manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products, which are sold in the United States, Canada, Europe, Asia, and other markets. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Cardinal Health, Inc.

Cardinal Health Opens Distribution Center In Texas, Plans One In California 

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$225.38
Prev Close	$226.34
Open	$225.29
Dividend Yield	0.86%
50-Day Moving Average	$233.55
Beta	0.23
Avg. Volume	1.86M
PE Ratio	31.14

52-Week High	$258.30
52-Week Low	$145.87
Market Capitalization	$52.42B
EPS (Annual)	$7.23
Price to Book	-18.21
Revenue Per Employee	$3.98M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CAH Fundamentals